How did PE investments in life sciences and healthcare fare in 2020, and what do this year and future years have in store for those sectors? In this episode, Dechert's Robert Darwin and senior PE leaders with experience at Blue Ox Healthcare, Mid Europa Partners, TPG and GHO Capital discuss key themes and opportunities affecting private equity investment in life sciences and healthcare and how the market is shaping up in the U.S. and Europe, in 2021 and beyond.